Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
?

?

2.610%
0.8
2.610%
-
 
07:33 / Stuttgart Stock Exchange WKN: A12FU4 / Symbol: ASTM / Name: Vericel / Stock / Pharmaceuticals / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction

Financial data and news for Vericel

sharewise wants to provide you with the best news and tools for Vericel, so we directly link to the best financial data sources.

News

Brown Capital Discloses $31 Million Sale of Vericel Stock as Small-Cap Biotech Reports Earnings: https://cdn.content.foolcdn.com/images/1umn9qeh/production/e3267fed451a2561633a53d0f6d2bd8d3aeda145-2667x1500.jpg?w=2667&h=1500
Brown Capital Discloses $31 Million Sale of Vericel Stock as Small-Cap Biotech Reports Earnings

On Tuesday, Baltimore-based Brown Capital Management reported selling 861,020 shares of Vericel Corporation for an estimated $30.9 million based on the average share price in the third quarter.

Vericel Q2 Revenue Jumps 20%
Vericel Q2 Revenue Jumps 20%

Vericel (NASDAQ:VCEL), a cell therapy specialist focused on sports medicine and burn care, reported its Q2 2025 results on July 31, 2025. The most headline-worthy news was the 20% year-over-year